Answers are grounded in this paper and cite their sources.
Leucine 9 ‐α‐melanotropin ([Leu 9 ]α‐MSH) was synthesized in homogeneous solution by a fragment condensation approach, and it was assayed for its melanophore‐dispersing and its tyrosinase‐stimulating activity with a reflectometric in vitro frog skin assay and with cultured mouse melanoma cells, respectively. In both assay systems, parallel log dose‐response curves were obtained for ([Leu 9 )]α‐MSH and α‐MSH; however, in the frog skin assay the activity of the title compound was 1 middot; 10 10 Units/mmol, i.e. 25% of the activity of α‐MSH, whereas its tyrosinasestimulating potency was only 1% compared to α‐MSH (EC 50 = 2.5 · 10 −7 M ). This indicates a major difference in the recognition/stimulation process of the receptors of the two cell types.
No takes yet. Share an insight, caveat, or question.
Eberlé et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: